Episode 46: Mary Anne Urlakis interviews Dr. Alan Moy, founder of Cellular Engineering Technologies (CET) (March 12, 2024)

In this episode of Inter Vitam et Mortem, Dr. Mary Anne Urlakis interviews Dr. Alan Moy, founder of Cellular Engineering Technologies (CET) (March 12, 2024)

In 2005, Dr. Moy left his tenured academic career to start a private solo pulmonary practice at a nearby Catholic hospital and started, on the same day, Cellular Engineering Technologies (CET), a biotech company with a modest goal of manufacturing adult stem cels. In 2006, he founded the non-profit John Paul II Medical Research Institute (JP2MRI). Initially the mission was to educate society on pro-life medical research ethics and advocate for the US to pursue adult stem cell research.

CET/JP2MRI developed biotechnology that is now superior and has the future potential to replace embryonic stem cells and aborted fetal cells that now commonly are used in the biopharmaceutical industry. While this change will not occur overnight, the scientific and business foundation is in place to support this vision. See the paper that was published in the Linacre Quarterly that describes Dr. Moy's journey. https://pubmed.ncbi.nlm.nih.gov/32549639/

Dr. Moy was recently asked to publish a paper on the challenges of induced pluripotent stem cells for the European Medical Society. https://pubmed.ncbi.nlm.nih.gov/38188933/

Both CET/JP2MRI are at an inflection point in their science and business to take off and hopefully achieve the vision that Dr. Moy started 2 decades ago.

Dr. Moy recently published an honest criticism directed towards Catholic and pro-life institutions. https://thefederalist.com/2024/02/12/this-one-abortion-story-changed-medicine-forever-but-pro-lifers-hardly-talk-about-it/